IVERIC bio
ISEE
$39.95
Share price
0.00%
Change (1 day)
248.91%
Change (1 year)
Categories
IVERIC bio (ISEE) - Cash on Hand
Cash on Hand as of March 2023 : $0.59 B
According to IVERIC bio's latest financial reports the company has $0.59 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
IVERIC bio - Cash on Hand chart (from 2012 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.64 B | 69.44% |
| 2021-12-31 | $0.38 B | 81.74% |
| 2020-12-31 | $0.21 B | 67.1% |
| 2019-12-31 | $0.12 B | -4.19% |
| 2018-12-31 | $0.13 B | -21.42% |
| 2017-12-31 | $0.16 B | -42.28% |
| 2016-12-31 | $0.28 B | -26.18% |
| 2015-12-31 | $0.39 B | -15.46% |
| 2014-12-31 | $0.46 B | 120.12% |
| 2013-12-31 | $0.21 B | 4792.42% |
| 2012-12-31 | $4.3 M | -32.7% |
| 2011-12-31 | $6.39 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -65.30% | 🇺🇸 USA |